HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis [Phase 3]
Phase 3 trial comparing daily versus intermittent regimen of ATT (anti-tuberculosis therapy) in patients with HIV and pulmonary tuberculosis…
-
FDA approval · 2019-04-08FDA Approved: DOVATO — Original Application (ViiV Healthcare Company)
The FDA approved Dovato, a fixed-dose combination of dolutegravir and lamivudine, under an original NDA for the treatment of HIV-1 infection…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS [Phase 3]
Phase 3 trial evaluating three chemotherapy regimens as an adjunct to ART for advanced AIDS-related Kaposi's sarcoma; completed with results…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024) [Phase 3]
Phase 3 study evaluating safety and efficacy of switching virologically suppressed HIV-1-infected participants to a doravirine/tenofovir/lam…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: 5 Years Follow-up Evaluation of Deterioration Kidney Biomarkers of HIV Patients [Phase 4]
A Phase 4 clinical trial provides a five-year follow-up evaluation of deteriorating kidney biomarkers in HIV patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: The Effectiveness of Dual Therapy (Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV Infected Patients in the Russian Federation
A completed clinical trial assessing the effectiveness of dual therapy with Lopinavir/ritonavir plus lamivudine in treatment-experienced HIV…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Darunavir and Rilpivirine Interactions With Levonorgestrel Implant [Phase 2]
Phase 2 clinical trial update evaluating interactions between darunavir/Rilpivirine and levonorgestrel implant for HIV-1 infection and contr…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant [Phase 2]
Phase 2 trial update examining interactions between darunavir and rilpivirine with the etonogestrel contraceptive implant in HIV and contrac…
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV [NA]
A completed clinical trial evaluating the feasibility of short-term PrEP uptake for men who have sex with men with episodic high-risk situat…
-
CLINICAL_TRIALS research · 2019-03-26Clinical Trial Update: Fish Oil for HIV-Related Inflamm-aging and Immune Senescence [NA]
Clinical trial on fish oil for HIV-related inflamm-aging and immune senescence has completed with results posted.
-
FDA approval · 2019-03-21FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
-
FDA approval · 2019-03-21FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention [Phase 2, Phase 3]
Phase 2/3 trial investigating reducing heavy drinking to improve HIV treatment and prevention outcomes has completed with posted results.
-
FDA approval · 2019-03-21FDA Approved: LAMIVUDINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic lamivudine as an original generic application for HIV-1 infection and chronic hepatitis B. This…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Integrated Treatment for Smoking Cessation & Anxiety in People With HIV [NA]
Clinical trial update on an integrated treatment approach for smoking cessation and anxiety in people with HIV; study completed with results…
-
FDA approval · 2019-03-18FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide).
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
A completed clinical trial evaluating renal, endocrine, and bone changes in uninfected young men who have sex with men taking FTC/TDF.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART [NA]
A completed clinical trial evaluating vitamin D absorption in HIV-infected young adults treated with tenofovir-containing combination antire…
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: Vitamin D HIV Study on Postmenopausal Women [Phase 1, Phase 2]
Clinical trial update for a Vitamin D study in postmenopausal women with HIV, reporting completed Phase 1 and Phase 2 results.
-
CLINICAL_TRIALS trial_result · 2019-03-07Clinical Trial Update: A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir [Phase 1]
Phase 1 study comparing tablet and capsule formulations of GSK2838232 with and without food, and evaluating safety and drug levels after rep…
-
CLINICAL_TRIALS research · 2019-03-05Clinical Trial Update: Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) [Phase 3]
Phase 3 trial evaluating strategies to reduce malaria burden in HIV-infected pregnant women and HIV-exposed children; study completed with r…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints [Phase 1, Phase 2]
A clinical trial investigating vorapaxar to attenuate D-dimer and target inflammatory and coagulation endpoints in HIV, completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study [Phase 3]
A Phase 3 trial comparing treatments for opioid use disorder and alcohol use disorder in HIV-infected individuals has completed with results…
-
FDA approval · 2019-02-25FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for SYMTUZA (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) from Janssen Produ…
-
CLINICAL_TRIALS trial_result · 2019-02-25Clinical Trial Update: Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients [Phase 4]
Phase 4 trial comparing raltegravir versus efavirenz combined with standard therapy in treatment-naïve HIV-1 patients; results posted after …